These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2939895)

  • 21. A method for the simultaneous isolation of factor X and prothrombin from bovine plasma.
    Esnouf MP; Lloyd PH; Jesty J
    Biochem J; 1973 Apr; 131(4):781-9. PubMed ID: 4737324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid purification of phospholamban by monoclonal antibody immunoaffinity chromatography.
    Suzuki T; Lui P; Wang JH
    Biochem Cell Biol; 1987 Apr; 65(4):302-9. PubMed ID: 2955797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conformation-specific monoclonal antibodies to the calcium-induced structure of protein C.
    Wakabayashi K; Sakata Y; Aoki N
    J Biol Chem; 1986 Aug; 261(24):11097-105. PubMed ID: 3525561
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Purification and preliminary characterization of rabbit vitamin K-dependent coagulation proteins.
    Weinstein RE; Rickles FR; Walker FJ
    Thromb Res; 1990 Aug; 59(4):759-72. PubMed ID: 2150452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isolation and properties of a blood coagulation factor X activator from the venom of king cobra (Ophiophagus hannah).
    Lee WH; Zhang Y; Wang WY; Xiong YL; Gao R
    Toxicon; 1995 Oct; 33(10):1263-76. PubMed ID: 8599178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of functionally important domains in human vitamin K-dependent protein S using monoclonal antibodies.
    Dahlbäck B; Hildebrand B; Malm J
    J Biol Chem; 1990 May; 265(14):8127-35. PubMed ID: 1692322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies on the purification of thrombopoietin from kidney cell culture medium.
    McDonald TP; Cottrell M; Clift R; Khouri JA; Long MD
    J Lab Clin Med; 1985 Aug; 106(2):162-74. PubMed ID: 4020244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human C4-binding protein. I. Isolation and characterization.
    Scharfstein J; Ferreira A; Gigli I; Nussenzweig V
    J Exp Med; 1978 Jul; 148(1):207-22. PubMed ID: 670886
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of precursor and secreted forms of human angiotensinogen.
    Campbell DJ; Bouhnik J; Coezy E; Menard J; Corvol P
    J Clin Invest; 1985 Jun; 75(6):1880-93. PubMed ID: 2989336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of an immunoaffinity process for factor IX purification.
    Tharakan J; Strickland D; Burgess W; Drohan WN; Clark DB
    Vox Sang; 1990; 58(1):21-9. PubMed ID: 2316207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunoaffinity purification of factor IX (Christmas factor) by using conformation-specific antibodies directed against the factor IX-metal complex.
    Liebman HA; Limentani SA; Furie BC; Furie B
    Proc Natl Acad Sci U S A; 1985 Jun; 82(11):3879-83. PubMed ID: 2408269
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High affinity interaction between C4b-binding protein and vitamin K-dependent protein S in the presence of calcium. Suggestion of a third component in blood regulating the interaction.
    Dahlbäck B; Frohm B; Nelsestuen G
    J Biol Chem; 1990 Sep; 265(27):16082-7. PubMed ID: 2144524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional properties of the sex-hormone-binding globulin (SHBG)-like domain of the anticoagulant protein S.
    Saposnik B; Borgel D; Aiach M; Gandrille S
    Eur J Biochem; 2003 Feb; 270(3):545-55. PubMed ID: 12542704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid purification of monoclonal antibodies by high-performance liquid chromatography.
    Pavlu B; Johansson U; Nyhlén C; Wichman A
    J Chromatogr; 1986 May; 359():449-60. PubMed ID: 3733939
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A coagulation pathway on bovine aortic segments leading to generation of Factor Xa and thrombin.
    Stern DM; Nawroth PP; Kisiel W; Handley D; Drillings M; Bartos J
    J Clin Invest; 1984 Dec; 74(6):1910-21. PubMed ID: 6439737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of prothrombin and of factor Xa-factor Va interactions upon inactivation of factor Va by activated protein C.
    Guinto ER; Esmon CT
    J Biol Chem; 1984 Nov; 259(22):13986-92. PubMed ID: 6438088
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Purification and characterization of guanosine 3',5'-monophosphate-inhibited low K(m) adenosine 3',5'-monophosphate phosphodiesterase from human placental cytosolic fractions.
    LeBon TR; Kasuya J; Paxton RJ; Belfrage P; Hockman S; Manganiello VC; Fujita Yamaguchi Y
    Endocrinology; 1992 Jun; 130(6):3265-74. PubMed ID: 1317779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The isolation of prothrombin, Factor IX and Factor X from human Factor IX concentrates.
    Modi GJ; Blajchman MA; Ofosu FA
    Thromb Res; 1984 Dec; 36(6):537-47. PubMed ID: 6084874
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of recombinant vitamin K-dependent proteins in mammalian cells: factors IX and VII.
    Berkner KL
    Methods Enzymol; 1993; 222():450-77. PubMed ID: 8412810
    [No Abstract]   [Full Text] [Related]  

  • 40. Discrimination of normal and abnormal prothrombin and protein C in plasma using a calcium ion-inhibited monoclonal antibody to a common epitope on several vitamin K-dependent proteins.
    Church WR; Bhushan FH; Mann KG; Bovill EG
    Blood; 1989 Nov; 74(7):2418-25. PubMed ID: 2804372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.